Carisma Therapeutics Inc. Quarterly Other Liabilities, Noncurrent in USD from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Carisma Therapeutics Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2014 to Q2 2024.
  • Carisma Therapeutics Inc. Other Liabilities, Noncurrent for the quarter ending June 30, 2024 was $815K, a 54.9% decline year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $815K -$994K -54.9% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.13M -$766K -40.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $926K -$115K -11% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $1.18M Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.81M Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.9M Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.04M +$1.04M Dec 31, 2022 10-K 2024-04-01
Q4 2021 $0 -$118K -100% Dec 31, 2021 10-K 2022-02-28
Q3 2021 $0 -$145K -100% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $43K Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $84K Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $118K +$118K Dec 31, 2020 10-K 2022-02-28
Q3 2020 $145K -$166K -53.4% Sep 30, 2020 10-Q 2020-11-09
Q4 2019 $0 -$313K -100% Dec 31, 2019 10-K 2021-03-15
Q3 2019 $311K $0 0% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $367K +$79K +27.4% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $398K +$138K +53.1% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $313K +$98K +45.6% Dec 31, 2018 10-K 2020-03-16
Q3 2018 $311K +$141K +82.9% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $288K +$140K +94.6% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 $260K Mar 31, 2018 10-Q 2018-05-15
Q4 2017 $215K +$215K Dec 31, 2017 10-K 2019-03-01
Q3 2017 $170K +$170K Sep 30, 2017 10-Q 2017-11-17
Q2 2017 $148K +$75K +103% Jun 30, 2017 10-Q 2017-08-14
Q4 2016 $0 -$423K -100% Dec 31, 2016 10-K 2018-04-02
Q3 2016 $0 -$275K -100% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $73K -$91K -55.5% Jun 30, 2016 10-Q 2016-08-12
Q1 2016 $81K +$16K +24.6% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $423K +$419K +10475% Dec 31, 2015 10-K 2017-03-24
Q3 2015 $275K Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $164K Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $65K Mar 31, 2015 10-Q 2015-04-30
Q4 2014 $4K Dec 31, 2014 10-K 2016-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.